Post-essential thrombocythemia myelofibrosis Clinical Trials

Delta Trials indexes 41 clinical trials for Post-essential thrombocythemia myelofibrosis in its publicly accessible dataset. Of these, 10 enrolling participants at this time and 15 trials have reached completion. This research takes place spanning 580 research sites around the world. An additional 16 trials are in preparatory or other active non-recruiting stages. Since 2020, 9 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.